Want to buy for someone else? You can purchase a token at check out.
This course is free with a membership upgrade!
Upgrade to a Standard membership and gain access to 1,000+ CE and professional development courses.
Overview
Cardiovascular disease (CVD) is attributed to 2 in 10 deaths in people under the age of 65, with coronary artery disease (CAD) being the leading cause of death in the U.S. (CDC, 2022a). It is estimated that 2.2 million people may die from CVD worldwide by 2030 (Patel et al., 2021). While coronary angiography is still considered the gold standard for coronary artery visualization, there are several noninvasive techniques that may also be used. These tests are important in the diagnosis and prognosis of CVD. This includes identifying arrythmias, assessing cardiac structure and function, or identifying the need for more invasive procedures (e.g., percutaneous coronary intervention [PCI]). Knowledge of these tests may be used to help facilitate timely testing and patients’ understanding of such tests to ease their anxiety.
Goals and Learning Outcomes
- Identify the various types of noninvasive diagnostic cardiac tests, including their purpose.
- Recall patient management and patient education that should be provided before and after noninvasive diagnostic cardiac tests, including expectations and potential adverse effects.
Course Details
Course Originally Released on : 10/7/2022
REL-ACU-0-NCDT
Course Author
BA, BSN, RN
Accreditations
NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider approved by the California Board of Registered Nursing, CEP#13791
Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.
CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.
Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.